Natural Killer T Cells in Cancer Immunotherapy

por Nair, Shiny, Dhodapkar, Madhav V.
Publicado 2017

Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?

por Dhodapkar, Madhav V., Dhodapkar, Kavita M.
Publicado 2019

Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention

por McCachren, Samuel S., Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Publicado 2021

Vigorous Premalignancy-specific Effector T Cell Response in the Bone Marrow of Patients with Monoclonal Gammopathy

por Dhodapkar, Madhav V., Krasovsky, Joseph, Osman, Keren, Geller, Matthew D.
Publicado 2003

Antitumor Monoclonal Antibodies Enhance Cross-Presentation of Cellular Antigens and the Generation of Myeloma-specific Killer T Cells by Dendritic Cells

por Dhodapkar, Kavita M., Krasovsky, Joseph, Williamson, Barbara, Dhodapkar, Madhav V.
Publicado 2002

Antigen-Specific Inhibition of Effector T Cell Function in Humans after Injection of Immature Dendritic Cells

por Dhodapkar, Madhav V., Steinman, Ralph M., Krasovsky, Joseph, Munz, Christian, Bhardwaj, Nina
Publicado 2001

Checkpoint Inhibition in Myeloma: Opportunities and Challenges

por Costa, Federica, Das, Rituparna, Kini Bailur, Jithendra, Dhodapkar, Kavita, Dhodapkar, Madhav V.
Publicado 2018

SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer

por Dhodapkar, Kavita M, Gettinger, Scott N, Das, Rituparna, Zebroski, Henry, Dhodapkar, Madhav V
Publicado 2013

Game of Bones: How Myeloma Manipulates Its Microenvironment

por Moser-Katz, Tyler, Joseph, Nisha S., Dhodapkar, Madhav V., Lee, Kelvin P., Boise, Lawrence H.
Publicado 2021

Serial exome analysis of disease progression in premalignant gammopathies

por Zhao, Siming, Choi, Murim, Heuck, Christoph, Mane, Shrikant, Barlogie, Bart, Lifton, Richard P., Dhodapkar, Madhav V.
Publicado 2014

Enhancement of clonogenicity of human multiple myeloma by dendritic cells

por Kukreja, Anjli, Hutchinson, Aisha, Dhodapkar, Kavita, Mazumder, Amitabha, Vesole, David, Angitapalli, Revathi, Jagannath, Sundar, Dhodapkar, Madhav V.
Publicado 2006

Conditional overexpression of TGFβ1 promotes pulmonary inflammation, apoptosis and mortality via TGFβR2 in the developing mouse lung

por Sureshbabu, Angara, Syed, Mansoor A, Boddupalli, Chandra Sekhar, Dhodapkar, Madhav V, Homer, Robert J, Minoo, Parviz, Bhandari, Vineet
Publicado 2015

A Reversible Defect in Natural Killer T Cell Function Characterizes the Progression of Premalignant to Malignant Multiple Myeloma

por Dhodapkar, Madhav V., Geller, Matthew D., Chang, David H., Shimizu, Kanako, Fujii, Shin-Ichiro, Dhodapkar, Kavita M., Krasovsky, Joseph
Publicado 2003

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program

por Dhodapkar, Kavita M., Banerjee, Devi, Connolly, John, Kukreja, Anjli, Matayeva, Elyana, Veri, Maria Concetta, Ravetch, Jeffrey V., Steinman, Ralph M., Dhodapkar, Madhav V.
Publicado 2007

Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program

por Dhodapkar, Kavita M., Banerjee, Devi, Connolly, John, Kukreja, Anjli, Matayeva, Elyana, Veri, Maria Concetta, Ravetch, Jeffrey V., Steinman, Ralph M., Dhodapkar, Madhav V.
Publicado 2007

Eliminating the monitoring period with subcutaneous daratumumab: a single-center experience

por Maples, Kathryn T., Hall, Kevin H., Joseph, Nisha S., Hofmeister, Craig C., Gupta, Vikas, Dhodapkar, Madhav V., Kaufman, Jonathan L., Nooka, Ajay K., Lonial, Sagar
Publicado 2023

Microenvironment-dependent growth of pre-neoplastic and malignant plasma cells in humanized mice

por Das, Rituparna, Strowig, Till, Verma, Rakesh, Koduru, Srinivas, Hafemann, Anja, Hopf, Stephanie, Kocoglu, Mehmet H., Borsotti, Chiara, Zhang, Lin, Branagan, Andrew, Eynon, Elizabeth, Manz, Markus G., Flavell, Richard A., Dhodapkar, Madhav V.
Publicado 2016

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance

por Boyiadzis, Michael M., Dhodapkar, Madhav V., Brentjens, Renier J., Kochenderfer, James N., Neelapu, Sattva S., Maus, Marcela V., Porter, David L., Maloney, David G., Grupp, Stephan A., Mackall, Crystal L., June, Carl H., Bishop, Michael R.
Publicado 2018

Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunity

por Moreno, Alberto, Manning, Kelly, Azeem, Maryam I., Nooka, Ajay K., Ellis, Madison, Manalo, Renee Julia, Switchenko, Jeffrey M., Wali, Bushra, Kaufman, Jonathan L., Hofmeister, Craig C., Joseph, Nisha S., Lonial, Sagar, Dhodapkar, Kavita M., Dhodapkar, Madhav V., Suthar, Mehul S.
Publicado 2023

Tandem high-dose influenza vaccination is associated with more durable serologic immunity in patients with plasma cell dyscrasias

por Branagan, Andrew R., Duffy, Eamon, Gan, Geliang, Li, Fangyong, Foster, Connor, Verma, Rakesh, Zhang, Lin, Parker, Terri L., Seropian, Stuart, Cooper, Dennis L., Brandt, Debra, Kortmansky, Jeremy, Witt, Davit, Ferencz, Thomas M., Dhodapkar, Kavita M., Dhodapkar, Madhav V.
Publicado 2021